Wakamoto Pharmaceutical Co., Ltd. (4512)
Market Closed
12 Aug, 06:00
JPX JPX Primary ¥
270. 00
+6
+2.2727%
¥
9.89B Market Cap
- P/E Ratio
7% Div Yield
58,600 Volume
- Eps
¥ 264
Previous Close Want to track 4512 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Wakamoto Pharmaceutical Co., Ltd. (4512) Statistics
Valuation metrics
Market Cap 9.89B
Enterprise value 7.52B
Trailing P/E (ttm) 40.15
Forward P/E -
PEG ratio -0.05
Price/Sales (ttm) 0.92
Price/Book (mrq) 0.76
Enterprise Value/Revenue 0.76
Enterprise Value/EBITDA 10.73
Overview
Shares outstanding 34.71M
Float 21.43M
Shares short -
% Held by insiders 0.46%
% Held by institutions 0.19%
Average volume (10 days) 38.2K
Average volume (90 days) 62.54K
Price summary
52-Week low 240
52-Week high 380
Beta 0.47
50-Day moving average 270.23
200-Day moving average 307.43
Financials
Fiscal year
Fiscal year ends 31 Mar 2012
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.02%
Operating margin 0.03%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.02%
Income Statement
Revenue (ttm) 9.43B
Revenue per share (ttm) 285.43
Quarterly revenue growth (yoy) -0.1%
Gross profit (ttm) 5.08B
EBITDA 22.23M
Net income to common (ttm) -222M
Diluted EPS (ttm) 6.55
Quarterly earnings growth (yoy) -0.1%
Balance Sheet
Total cash (mrq) 1.87B
Total cash per share (mrq) 57.8
Total debt (mrq) 1.66B
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 3.48%
Book value per share (mrq) 345.99
Cash Flow
Cash flow statement 589M
Levered free cash flow (LFCF) -241M
